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ABSTRACT 
 
HIV infection is one of the health problems plaguing resource-poor countries. There are limited data on the 
prevalence in remote towns and districts. In this study, we aimed at investigating the seroprevalence of HIV in 
Moyamba District using data from voluntary counseling and testing(VCT), prevention of mother-to-child 
transmission of HIV(PMCT) and from blood donors from 2013 to 2016. 
 
The seroprevalence of HIV from VCT was 2.87%(357/12434) for the four years, 2013 to 2016. Seroprevalence 
from PMCT was 0.91%(153/16,745) while the prevalence from healthy blood donors was 1.53%(27/1756). 
Overall, 537 persons tested positive for HIV out of 30,935 persons tested in Moyamba from 2013 to 2016 with 
a prevalence of  1.74(95%CI:1.6-1.89%). 
 
Statistically, our result is  significantly  different from the results  of the DHS where HIV 
seroprevalence was reported at 1.0% in Moyamba(P<0.001). 
 
Our result provides an update on the HIV situation in Moyamba and shows an epidemic that is consistent with 
the national seroprevalence of 1.5%. 
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BACKGROUD 
 
In Sierra Leone, the first reports of HIV were in 
1987(NAS/MOHS 2002). The country then had about 
11 years of civil war from 1991 to 2002. The war was 
characterized by massive displacement of people, 
rape, high level of prostitution that seemed to 
accelerate the HIV prevalence (Human Rights Watch 
2003).  
 
Serious countrywide interventions against HIV 
commenced in the year 2002, when Sierra Leone had 
the first national HIV seroprevalence (NAS/MOHS 
2002) and also established the prevention of mother-
to-child transmission (PMCT) policy that required all 
pregnant women to be tested for HIV 
(http://www.nas.gov.sl/interventions/pmtct, 
accessed, 9/12/16). Voluntary counseling and 
testing(VCT) and screening of blood products for HIV 
had been instituted earlier.  
 
However, about 49% of women and 82% of men are 
yet to be tested for HIV (NAS/MOHS 2015). The low 
level of HIV testing has been associated with stigma 
and lack of appropriate understanding about HIV 
(Bhoobun et al., 2014, Kelly, Weiser, & Tsai, 2016).  
 
Population-based surveys were carried out in 2008 
and 2013 reporting the national HIV prevalence to 
be stabilized and at 1.5% seroprevalence (Statistics 
Sierra Leone and ICF International 2014). And the 
epidemic currently affects over 50,000 persons 
including about 2166 new infections and there are 
about 23,000 orphans due to the HIV problem in 
Sierra Leone (WHO 2016). 
 
In Moyamba, the site of this study, apart from the 
DHS reports, there is a paucity of data on HIV 
epidemic. A peek into the HIV situation in Moyamba  
district was observed during the Ebola outbreak, 
when several suspected EVD patients were 
diagnosed with HIV and posed challenges in EVD 
treatment (Arranz et al, 2016). 
 
Screening for HIV using established programmes 
such as the VCT, PMCT and blood donor screening 
are important for determining the HIV situation in a 
remote population such as Moyamba. 
 
The goal of this study was to determine the 
seroprevalence of HIV in Moyamba from healthy 






The study was carried out in the Moyamba District 
which is one of four districts in Southern Sierra 
Leone and has a land area of The study was carried 
out in the Moyamba District which is one of four 
districts in Southern Sierra Leone and has a land 
area of 6902km2. The land is divided into 14 
chiefdoms which asre further divided into 143 
sections, and a total of 1617 communities (DOtW 
and MdM 2015).  The population of   Moyamba  is 
reported at 318,064 persons(Statistics Sierra Leone 
2016), 70% of which live in poverty( DOtW and MdM 
2015).  
 
We analyzed data collected from VCT, PMCT and 
blood donors at the Moyamba Hospital from the year 
2013 to 2016. The data was collated from hospital 
records. The HIV results were from HIV tests done 
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MT (males tested), MP (males positive), FT (females tested), FP (Females positive), TT (total tested), 
TP (total positive) %P (% prevalence) 
 
YEAR  MT   MP   %P   FT   FP   %P   TT   TP   %P   
P-
Value  
2013  2187  37  1.69  3686  133  3.6  5873  170  2.89  0.0001   
2014   1512   45   2.98   1995   61   3.06   3507   106   3.02  0.89   
2015   650     15   2.31   1340   53   3.96   1990   68   3.42   0.06   
2016   440     6   1.36   624   7   1.12   1064   13   1.22  0.72   
Total   4789   103   2.15   7645   254   3.32   12434   357   2.87   0.0001   
Determine HIV kit Determine™ HIV-1/2 (Alere 
Medical Co Ltd. Matsudo-shi, Chiba, Japan), a 
positive test was confirmed by the SD Bioline 
HIV1/2 test kit ((Standard Diagnostics Inc. 
Kyonggi-do, Korea). In the event of a tie, the Uni-
Gold HIV kit (Trinity Biotech, Ireland) was used. 
For blood donation, subjects were to have Hb 
values =12g/dL. 
 
The study was a requirement for the 
undergraduate degree in Biological Sciences at 
the Njala University, by the lead author(AV).  
Statistical analyses were done using the 
online statistical software package Vassar stats 
(http://vassarstats.net/). The computations 
involved percentages, chi- 
Determine HIV kit Determine™ HIV-1/2 (Alere 
Medical Co Ltd. Matsudo-shi, Chiba, Japan), a 
positive test was confirmed by the SD Bioline 
HIV1/2 test kit ((Standard Diagnostics Inc. 
Kyonggi-do, Korea). In the event of a tie, the Uni-
Gold HIV kit (Trinity Biotech, Ireland) was used. 
For blood donation, subjects were to have Hb 
values =12g/dL. 
 
The study was a requirement for the 
undergraduate degree in Biological Sciences at 
the Njala University, by the lead author(AV).  
Statistical analyses were done using the 
online statistical software package Vassar stats 
(http://vassarstats.net/). The computations 
involved percentages, chi- 
Table 1.0: VCT in Moyamba, 2013-2016 
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Seroprevalence of HIV from PMCT, 2013 to 
2016 
 
For the period covered by the study, 2013 to 
2016, 16,745 women were tested by PMCT in 
Moyamba and 153(0.91%) were positive for HIV 
(Table 2). There was a significant difference 
between prevalence in 2015 and 2014(P=0.001) 
and also between the rates in 2015 and 
2013(P=00.1). 
 
Table 2: PMCT in Moyamba, 2013-2016 
 
YEAR       PMCT   WP  %P  
P-
value  
2013  2157  27  1.25   
2014  3576  47  1.31     0.84 
2015  6011  40  0.66    0.001 
2016  5001  39  0.77     0.48 
TOTAL  16,745  153 0.91       
 
Seroprevalence of HIV from Healthy Blood 
Donors, 2013-2016 The seroprevalence from 
healthy blood donors at the Moyamba 
Government Hospital were also assessed. The 
seroprevalence was 2.61% in 2013; 0.66% in 
2014, 1.33% in 2015 and 1.28% in 
2016(Table 3). The overall seroprevalence for 
the four-year period was 1.53%(27/1756). 















































































































































































































Table 3: Prevalence of HIV in Blood 
Donors 
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The seroprevalence of HIV from the three data 
sources ranged from a minimum of 0.66% to 
3.42%.  When data from VCT, PMCT and blood 
donors and put together, 537 persons tested 
positive for HIV out of 30,935 persons tested in 
Moyamba from 2013 to 2016 with a prevalence 
of 1.74(95%CI:1.6-1.89%).  
 
Statistically, our result is significantly different 
from the results of the DHS where HIV 
seroprevalence was reported at 1.0% in 
Moyamba(P<0.001), however our result is not 
significantly different from the national 
seroprevalence rate of 1.5%(Statistics Sierra 
Leone and ICF International 2014).  
 
Our PMCT rates reported is under 1% just like 
the one reported by Kouyoumdjian et al, (2008) 
of 0.58%(7/1208) among women seeking 
antenatal care in Kenema District.  
 
The prevalence among blood donors, who are 
healthy volunteers seemed to match with the 
1.5% stabilized epidemic described earlier 
(NAS/MOHS 2015).  
 
VCT prevalence was expected to be higher than 
the PMCT and blood donor HIV prevalence. Many 
VCT clients normally opt for an HIV tests after 
potential exposures to the virus.   
 
Our study had several limitations. First, we used 
data collected and entered into hospital records, 
we did not generate the data primarily and could 
not ascertain whether the test kits were stored at 





inserts or if the tests were done within the 
specified time indicated in the user inserts. We 
do however know that the tests were 
performed by trained and qualified technicians 
who could have performed according to the 
guidelines by the Sierra Leone Ministry of 
Health and Sanitation.  
 
Additionally, we were unable to use age  
metadata because the data did not have age 




Our result provides an update on the HIV  
situation in Moyamba and shows an epidemic 
that is consistent with the national 
seroprevalence of 1.5%. Our findings from 
PMCT, VCT and blood donors relate with 
recent international calls for HIV 
surveillance(Supervie and Costagliola 2016; 
UNAIDS 2014; van Sighem et al. 2015).  
 
Further research on HIV using a randomized 
study design with healthy volunteers in a 
longitudinal cohort could help to determine 
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